fbpx

Normal

The University is currently operating under normal conditions

Research

Research at UNC-Chapel Hill, a billion-dollar venture, has quadrupled over the past 15 years, firmly establishing Carolina as one of America’s top-ranked research universities.

Student works with chemicals.

Collaborative approach, world-renowned research

Cures and treatments for disease. New technologies. New industries for North Carolina and the world.  At Carolina, we tackle tough challenges with multidisciplinary teams of top scientists and students whose diverse perspectives deliver creative, unprecedented solutions. As one of America’s top research universities, we conduct roughly $1 billion in research annually. We provide dedicated service to our sponsors and unprecedented opportunities for graduate students, postdocs and undergraduates.

Read more.

Facts & Figures

  • 11thlargest U.S. research university (research volume & annual expenditures)
  • 5thin the U.S. for federal research among public and private universities
  • $1.10 billionin annual research activity
  • 62%of all UNC system research performed by UNC-Chapel Hill
  • For every $1of state funding, research centers & institutes attract $8 from external sources

Serving North Carolina,
Changing the World

Carolina is a world-class research university where great ideas and creativity flow, innovations are put to the test, and discoveries are made.

  • In it for the long haul

    For some COVID-19 patients, the initial infection is just the start of the battle. Post-COVID syndrome occurs when a person’s symptoms continue long after their infection ends. A new clinic at Carolina hopes to not only help these patients, but also provide researchers with valuable data about this strange syndrome.

  • A legacy of precision nutrition

    Dr. Steven Zeisel will be stepping down as the UNC Nutrition Research Institute’s director after 13 years, but he leaves behind a legacy that has helped shape a more comprehensive picture of nutrition.

  • READDI, not reactive

    The Rapidly Emerging Antiviral Drug Discovery Initiative — founded by researchers at Carolina and the Structural Genomics Consortium — is not only finding solutions to the COVID-19 pandemic, but also drugs and therapeutics for future viral outbreaks.

Around Campus